Yashwant Medical And Research Foundation Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 22-05-2024
- Paid Up Capital ₹ 1.75 M
as on 22-05-2024
- Company Age 26 Year, 3 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 M
as on 22-05-2024
- Satisfied Charges ₹ 0.60 M
as on 22-05-2024
- Revenue 33.91%
(FY 2021)
- Profit -100.39%
(FY 2021)
- Ebitda -119.44%
(FY 2021)
- Net Worth -0.05%
(FY 2021)
- Total Assets -3.59%
(FY 2021)
About Yashwant Medical And Research Foundation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.75 M.
The company currently has active open charges totaling ₹9.00 M. The company has closed loans amounting to ₹0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Geetanjali Gondkar, Shalaka Kawade, and Shodhan Gondkar serve as directors at the Company.
- CIN/LLPIN
U99999MH1998PLC118729
- Company No.
118729
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Dec 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Yashwant Medical And Research Foundation?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geetanjali Gondkar  | Director | 07-Feb-2006 | Current |
| Shalaka Kawade | Director | 21-Dec-1998 | Current |
| Shodhan Gondkar | Director | 21-Dec-1998 | Current |
Financial Performance of Yashwant Medical And Research Foundation.
Yashwant Medical And Research Foundation Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 33.91% increase. The company also saw a substantial fall in profitability, with a 100.39% decrease in profit. The company's net worth dipped by a decrease of 0.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yashwant Medical And Research Foundation?
In 2020, Yashwant Medical And Research Foundation had a promoter holding of 95.90% and a public holding of 4.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Jan Laxmi Co.Op. Bank Ltd. Creation Date: 05 Jul 1999 | ₹9.00 M | Open |
The Saraswat Co-Operative Bank Ltd. Creation Date: 24 Nov 2009 | ₹0.60 M | Satisfied |
How Many Employees Work at Yashwant Medical And Research Foundation?
Unlock and access historical data on people associated with Yashwant Medical And Research Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yashwant Medical And Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yashwant Medical And Research Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
